Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($)	Jun. 30, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 3,701,453	$ 8,715,279
Marketable securities	1,981,180	0
Accounts receivable, net	789,584	693,717
Prepaid expenses and other current assets	551,990	443,872
Inventories	2,193,063	1,792,335
Advances on contracts	1,282,806	1,325,301
Total current assets	10,500,076	12,970,504
Furniture, fixtures and equipment, net	11,867	18,146
Intangibles, net	201,529	227,956
Right of use assets finance lease	13,319	17,645
Right of use assets operating lease	400,511	443,685
Other assets	24,150	24,150
Total assets	11,151,452	13,702,086
Current liabilities:
Accrued expenses and other payables	1,422,506	1,124,839
Accrued expenses, related party	278,339	167,549
Current portion of finance lease liabilities	9,805	9,365
Current portion of operating lease liabilities	97,429	91,701
Total current liabilities	3,109,356	3,299,675
Non-current portion of finance lease liabilities	5,683	10,698
Non-current portion of operating lease liabilities	334,750	385,279
Total liabilities	3,449,789	3,695,652
Commitments
Stockholders’ equity
Common stock, par value $.001;authorized 100,000,000 shares; 70,107,739 shares issued and 70,074,406 shares outstanding as of June 30, 2023; 69,306,497 shares issued and 69,273,164 shares outstanding as of December 31, 2022;	70,108	69,306
Additional paid in capital	128,720,911	127,478,325
Accumulated deficit	(119,934,388)	(116,410,405)
Treasury stock, at cost, 33,333 shares	(911,516)	(911,516)
Total Milestone Scientific, Inc. stockholders' equity	7,945,115	10,225,710
Noncontrolling interest	(243,452)	(219,276)
Total stockholders’ equity	7,701,663	10,006,434
Total liabilities and stockholders’ equity	11,151,452	13,702,086
Nonrelated Party [Member]
Current liabilities:
Accounts payable	674,587	1,102,729
Related Party [Member]
Current liabilities:
Accounts payable	$ 626,690	$ 803,492